NCT07536412 2026-04-17
Decision Aid Efficacy in Low Risk Thyroid Cancer
University of Maryland, Baltimore
Phase NA Not yet recruiting
Clinical Trials
16 trialsNCT04104529 2026-02-05
BCB RIV
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT05534594 2025-06-24
MIMETIC
University Medical Center Groningen
Phase NA Completed
NCT04129411 2025-05-20
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
Mayo Clinic
Phase NA Completed
NCT06971965 2025-05-14
MAeSTro-TSH
National Cancer Center, Korea
Phase NA Not yet recruiting
NCT06730893 2025-04-30
MAeSTro-SDM
National Cancer Center, Korea
Phase NA Not yet recruiting
NCT05003856 2025-04-02
Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule
M.D. Anderson Cancer Center
Phase NA Terminated
NCT06804863 2025-02-03
Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer
West China Hospital
Phase NA Not yet recruiting
NCT05507775 2024-04-11
DIGUP-TC
Radboud University Medical Center
Phase NA Completed
NCT03986593 2023-07-05
Cryoablation of Bone Metastases From Endocrine Tumors
Instituto do Cancer do Estado de São Paulo
Phase NA Terminated
NCT04424485 2020-06-11
Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy
Umraniye Education and Research Hospital
Phase NA Unknown
NCT03411187 2018-09-18
Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy
Fujian Medical University
Phase NA Unknown
NCT00416949 2018-07-18
Iodine I 131 in Treating Patients With Thyroid Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Terminated
NCT01534897 2017-03-15
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
Massachusetts General Hospital
Phase NA Completed
NCT02648399 2016-01-07
Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma
Fujian Medical University
Phase NA Unknown
NCT00068497 2013-01-14
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase NA Completed